Pricing Log in Create free account
Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%
Market cap
$34.8B
P/E
41.0×
Fwd P/E
31.5×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Biogen Inc. (BIIB) Current ratio

Alert me on Current ratio

Biogen Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.9×, down 0.8× from fiscal 2025 (2.7×). Over the past ten years it has ranged from 1.3× (fiscal 2024) to 3.0× (fiscal 2022); the current reading is higher than 91% of that period. That is above the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.7× 98.66%
FY2024 1.3× (32.47%)
FY2023 2.0× (33.24%)
FY2022 3.0× 63.67%
FY2021 1.8× (0.68%)
FY2020 1.8× 6.80%
FY2019 1.7× (25.68%)
FY2018 2.3× (0.80%)
FY2017 2.3× (8.45%)
FY2016 2.6× (1.77%)

Quarterly newest first

Period Current ratio Change
Jun 2026 1.9× (39.14%)
Mar 2026 3.1× 14.38%
Dec 2025 2.7× (1.36%)
Sep 2025 2.7× 8.53%
42 more quarters

Against its own ten years

Low 1.3× High 3.0×
Ten-year median 2.3×
Current reading's percentile 91

Current ratio against peers

Company Current ratio
BIIB Biogen Inc. 1.9×
BMY Bristol Myers Squibb Company compare 1.5×
AMGN Amgen Inc. compare 1.4×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
SNY Sanofi compare 1.0×
AZN AstraZeneca PLC compare 0.9×
NVO Novo Nordisk A/S compare 0.9×
GSK GSK PLC Sponsored ADR compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on BIIB